Delivery Order SPE2DB20D2014-SPE2DB25FC79N
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of ENGERIX-B 20 MCG/ML vaccine syringes with a ceiling value of $18,217.83. This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by August 11, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement supporting...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Engerix-B 20 mcg/mL syringes, with a ceiling value of $1,662.69. This firm fixed-price delivery order is scheduled for ultimate completion by August 5, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen Drug Corp's demonstrated...
- The Defense Logistics Agency awarded a $1,837.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ENGERIX-B 20 mcg/mL vaccine syringes on August 7, 2025, with an ultimate completion date of August 8, 2025. This non-set-aside contract was performed at the contractor's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's broader pharmaceutical supply relationship with DLA. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes valued at $9,034.57 under a firm fixed price contract type. The award was made on July 18, 2025, with an ultimate completion date of July 21, 2025, and represents a competitively awarded, non-set-aside procurement. AmerisourceBergen will perform this delivery order from its corporate office location in Conshohocken, Pennsylvania, where the company serves as a major...
- The Defense Logistics Agency awarded a delivery order valued at $14,315.65 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes, with performance in Conshohocken, Pennsylvania. This firm fixed price, non-set-aside contract was competitively awarded and is scheduled for completion by August 15, 2025. The award represents a single delivery order transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,030.56 for ENGERIX-B 20 MCG/ML vaccine syringes, with a completion deadline of July 31, 2025. This is a firm fixed price delivery order with no set-aside designation, issued competitively to the major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The award represents a small-value transaction under AmerisourceBergen's broader federal contract portfolio supporting military and...
- The Defense Logistics Agency awarded a delivery order valued at $1,751.90 to AmerisourceBergen Drug Corp for ENGERIX-B 20 micrograms per milliliter syringes on July 29, 2025, with completion scheduled for July 30, 2025. This competitively awarded contract utilizes firm fixed pricing with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and healthcare solutions provider to federal medical procurement needs,...
- The Defense Logistics Agency awarded a $1,954.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes, with an ultimate completion date of August 21, 2025. This non-set-aside competitive award is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- The Defense Logistics Agency awarded a delivery order valued at $1,734.75 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine (20 micrograms per milliliter syringes). This competitively awarded, firm fixed-price delivery order was issued on July 18, 2025, with an ultimate completion date of July 21, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation. This delivery order is a child contract under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,212.20 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes. This firm fixed price, competitively awarded contract is scheduled for completion by July 23, 2025, and represents a non-set-aside procurement from the pharmaceutical distributor's corporate office in Conshohocken, Pennsylvania. The delivery order was executed on July 22, 2025, as part of the federal government's ongoing medical supply...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC79NDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Engerix-B 20 mcg/mL vaccine syringes valued at $1,954.32. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 21, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting open competition in the federal procurement process. This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.9 billion prime vendor agreement extending through December 2026. This IDC serves as the primary vehicle for supplying pharmaceutical products, vaccines, and medical supplies to support military healthcare systems globally. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen leverages this contract to fulfill supply requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 8/20/25 |